RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
Type 2 diabetes, characterized by target-tissue resistance to insulin, is epidemic in industrialized societies and is strongly associated with obesity; however, the mechanism by which increased adiposity causes insulin resistance is unclear. Adipocytes secrete a unique signalling molecule, which was named resistin (for resistance to insulin). Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity. Administration of anti-resistin antibody improves blood sugar and insulin action in mice with diet-induced obesity. Moreover, treatment of normal mice with recombinant resistin impairs glucose tolerance and in...
View Complete Description Individual Studies |
|
|---|---|
|
|
Authors: Christopher T Kodl, Elizabeth R Seaquist
Endocrine reviews 2008 JunAuthors: Lydia Aguilar-Bryan, Joseph Bryan
Endocrine reviews 2008 MayThought leaders and organizations working on research involving Diabetes mellitus.
conditions: Diabetes ; Diabetes Mellitus ; Hypertension
interventions: Health Information ; Preventive Services ; Computer tailored information
conditions: Insulin-Dependent Diabetes Mellitus ; Diabetes Mellitus
interventions: IBC-VS01 ; IBC-VS01 placebo
Asist.univ.
University of Medicine and Pharmacy "Iuliu Hatieganu"
MD
Casa di Cura Triolo Zancla
25 members